Total Payments
$6,443
2024 Payments
$2,429
Companies
15
Transactions
405
Medicare Patients
6,973
Medicare Billing
$428,982
Payment Breakdown by Category
Food & Beverage$5,884 (91.3%)
Education$558.68 (8.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,884 | 398 | 91.3% |
| Education | $558.68 | 7 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,705 | 173 | $0 (2024) |
| Janssen Biotech, Inc. | $1,557 | 77 | $0 (2024) |
| Incyte Corporation | $714.63 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $507.76 | 27 | $0 (2024) |
| GENZYME CORPORATION | $497.57 | 23 | $0 (2024) |
| Lilly USA, LLC | $479.64 | 31 | $0 (2024) |
| LEO Pharma Inc. | $290.35 | 14 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $190.12 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $171.00 | 2 | $0 (2024) |
| UCB, Inc. | $140.76 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,429 | 144 | ABBVIE INC. ($601.84) |
| 2023 | $1,922 | 122 | Janssen Biotech, Inc. ($667.88) |
| 2022 | $1,509 | 94 | ABBVIE INC. ($476.94) |
| 2021 | $582.75 | 45 | AbbVie Inc. ($251.83) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $133.15 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.87 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Podiatry | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.90 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,634 | 4,285 | $582,628 | $158,631 |
| 2022 | 22 | 2,347 | 3,552 | $537,338 | $151,825 |
| 2021 | 15 | 1,093 | 1,487 | $242,880 | $72,129 |
| 2020 | 10 | 899 | 1,306 | $186,160 | $46,397 |
Total Patients
6,973
Total Services
10,630
Medicare Billing
$428,982
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 524 | 757 | $127,352 | $39,643 | 31.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 494 | 564 | $128,713 | $36,252 | 28.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 270 | 270 | $60,992 | $14,950 | 24.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 404 | 471 | $68,577 | $13,783 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 171 | $41,379 | $13,028 | 31.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 320 | 1,537 | $28,756 | $7,055 | 24.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 46 | 52 | $19,324 | $5,126 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $19,848 | $5,062 | 25.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 117 | 125 | $12,901 | $3,902 | 30.2% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 34 | 40 | $11,540 | $2,934 | 25.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 32 | 37 | $9,439 | $2,492 | 26.4% |
| 17280 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 28 | 29 | $8,518 | $2,386 | 28.0% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 18 | 20 | $8,240 | $2,384 | 28.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 20 | 23 | $7,485 | $2,343 | 31.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $7,168 | $1,944 | 27.1% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 15 | 15 | $5,150 | $1,433 | 27.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 34 | 34 | $5,198 | $1,075 | 20.7% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 27 | 27 | $4,824 | $1,065 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 22 | 22 | $4,538 | $1,033 | 22.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $2,686 | $741.43 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 512 | 817 | $126,635 | $42,276 | 33.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 482 | 543 | $122,175 | $35,291 | 28.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 309 | 309 | $69,525 | $18,368 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 110 | $24,750 | $8,685 | 35.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 264 | 295 | $45,725 | $7,350 | 16.1% |
About Peter Eichwald, NURSE PRACTITIONER
Peter Eichwald, NURSE PRACTITIONER is a Family healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1992257778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Eichwald, NURSE PRACTITIONER has received a total of $6,443 in payments from pharmaceutical and medical device companies, with $2,429 received in 2024. These payments were reported across 405 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,884).
As a Medicare-enrolled provider, Eichwald has provided services to 6,973 Medicare beneficiaries, totaling 10,630 services with total Medicare billing of $428,982. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Redding, CA
- Active Since 10/27/2016
- Last Updated 04/19/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992257778
Products in Payments
- TREMFYA (Drug) $1,267
- DUPIXENT (Biological) $1,176
- SKYRIZI (Biological) $880.13
- OPZELURA (Drug) $714.63
- RINVOQ (Biological) $673.29
- TALTZ (Drug) $479.64
- ADBRY (Biological) $290.35
- REMICADE (Biological) $273.01
- HUMIRA (Biological) $143.02
- JUBLIA (Drug) $94.52
- SILIQ (Drug) $80.68
- Cimzia (Drug) $70.86
- Bimzelx (Biological) $69.90
- VTAMA (Drug) $64.69
- Winlevi (Drug) $44.06
- Sotyktu (Drug) $27.31
- COSENTYX (Biological) $23.62
- XOLAIR (Drug) $16.07
- ARAZLO (Drug) $14.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Redding
Faith Clause, Fnp, FNP
Family — Payments: $10,341
Family $10,341
Adam Bierman, Fnp, FNP
Family — Payments: $8,290
Family $8,290
Mrs. Rebecca Lewis, Fnp, FNP
Family — Payments: $7,651
Family $7,651
Mrs. Cherie Booker, Fnp, FNP
Family — Payments: $7,572
Family $7,572
Mrs. Paula Amacker, Fnp, FNP
Family — Payments: $5,491
Family $5,491
Mrs. Stacia Mcfarland, Fnp, FNP
Family — Payments: $5,263
Family $5,263